Related Experiment Videos

Acute respiratory distress syndrome in children: a 10 year experience

G Paret1, T Ziv, A Augarten

  • 1Department of Pediatric Intensive Care, Sheba Medical Center, Tel-Hashomer, Israel. gparet@post.tau.ac.il

Insights

This study found that pediatric acute respiratory distress syndrome (ARDS) has a high mortality rate, comparable to adult outcomes. Key predictors of death in children include low PaO2/FIO2 and high alveolar-arterial O2 difference within two days of diagnosis.

Area of Science:

  • Pediatric critical care medicine
  • Respiratory physiology
  • Pulmonary medicine

Background:

  • Acute Respiratory Distress Syndrome (ARDS) is a severe condition characterized by high-permeability pulmonary edema and significant morbidity.
  • Understanding ARDS in children is crucial due to its high mortality and complex presentation.

Purpose of the Study:

  • To analyze a decade of pediatric ARDS cases.
  • Identify predisposing factors, clinical course, and mortality predictors in pediatric ARDS.
  • Establish a local risk profile for early intervention.

Main Methods:

  • Retrospective review of pediatric intensive care unit admissions over 10 years.
  • Inclusion criteria for ARDS: acute onset, diffuse bilateral infiltrates (non-cardiac), severe hypoxemia (PaO2/PEEP < 200) for ≥24 hours.
  • Data collected: demographics, clinical course, physiological parameters (PaO2/FIO2, A-aDO2, ventilation index).

Main Results:

  • 39 pediatric ARDS cases identified; mean age 7.4 years.
  • Common predisposing factors: sepsis, pneumonia, malignancy, trauma, shock.
  • Mortality rate was 61.5%.
  • Second-day predictors of mortality: PaO2/FIO2, ventilation index, and A-aDO2.
  • Nonsurvivors showed significantly lower PaO2/FIO2 and higher A-aDO2 and ventilation index compared to survivors.

Conclusions:

  • Pediatric ARDS outcomes in this cohort are comparable to international tertiary centers.
  • PaO2/FIO2, A-aDO2, and ventilation index are valuable early predictors of outcome in pediatric ARDS.
  • Developing a local risk profile can facilitate timely application of novel therapies.
Abstract

Related Concept Videos